Prescott Group Capital Management’s ResMed RMD Stock Holding History

Prescott Group Capital Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-10,000	Closed	-$1.15M	–	248
2018 Q3	$1.15M	Hold	10,000	–	–	0.23%	106
2018 Q2	$1.04M	Hold	10,000	–	–	0.19%	122
2018 Q1	$985K	Hold	10,000	–	–	0.21%	116
2017 Q4	$847K	Hold	10,000	–	–	0.18%	116
2017 Q3	$770K	Hold	10,000	–	–	0.16%	118
2017 Q2	$779K	Hold	10,000	–	–	0.16%	114
2017 Q1	$720K	Buy	+10,000	New	+$691K	0.16%	115

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Prescott Group Capital Management's RMD Position: Q4 2018 in Review

Prescott Group Capital Management sold out of ResMed (RMD) in Q4 2018, closing a stake of 10,000 shares — an estimated $1.15M sold.

Prescott Group Capital Management first reported a position in RMD in Q1 2017 and held it in 7 quarters. The position peaked at $1.15M in Q3 2018. 501 funds tracked by Wall St. Rank hold RMD as of Q4 2018.

Prescott Group Capital Management reported no remaining ResMed position as of Q4 2018 after selling out during the quarter.
Prescott Group Capital Management sold 10,000 ResMed shares in Q4 2018, an estimated $1.15M.
Prescott Group Capital Management first reported a position in ResMed in Q1 2017 and held it in 7 quarters.
Prescott Group Capital Management's ResMed position peaked at $1.15M in Q3 2018.
501 funds tracked by Wall St. Rank held ResMed as of Q4 2018.

Based on Prescott Group Capital Management's 13F filing for Q4 2018, filed 11 Feb 2019.